Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Monitor your blood glucose levels
You can't change your genes, but you can meaningfully influence how much GLP-1 your gut releases through what you eat and how you live
Special considerations: children and adolescents Several GLP-1RAs, including liraglutide and dulaglutide, are approved for treating children and adolescents with type 2 diabetes
Eliquis (Pfizer/Bristol Myers Squibb) holds firm at $22.4B, Dupixent (Sanofi/Regeneron) climbs to $17.8B, and Skyrizi (AbbVie) at $17.6B - a strong signal that immunology remains highly profitable, even as Humira biosimilars continue to dominate
Important Update: As of May 2025, compounded semaglutide is no longer available for routine compounding following the FDAs determination that the semaglutide shortage has been resolved
